Objective To estimate obstetrician-gynecologists'(ob-gyns) willingness to provide medication
abortion if the in-person dispensing requirement for mifepristone were removed. Study …

Objective Medication abortion is safe and effective, yet access is limited by a strict Risk
Evaluation and Mitigation Strategy (REMS) that prohibits pharmacy dispensing of …

Objective (s) To estimate the effectiveness, acceptability, and feasibility of medication
abortion with mifepristone dispensed by a mail-order pharmacy after in-person clinical …

Objectives To discuss the potential for improving access to early abortion care through
pharmacies in the United States. Summary Despite the growing use of medications to …

Abstract Objectives: In 2000, the United States' Food and Drug Administration (FDA)
approved mifepristone for medication abortion. In this article, we explore how the Risk …

Abstract Introduction Until December 2021, the United States Food and Drug Administration
impeded abortion access by restricting pharmacists from dispensing mifepristone, one of two …

Objective Given the substantial barriers to abortion access in the United States, many clinics
now mail patients abortion medications. We examined whether dispensing the medications …

Objective Protocols including mifepristone are the most effective medication regimens for
medication abortion and early pregnancy loss (EPL) management. Both can be safely and …

OBJECTIVE: To estimate effectiveness and acceptability of medication abortion with
mifepristone dispensed by pharmacists. METHODS: We conducted a prospective cohort …

• Physician-only dispensing could necessitate that doctors obtain special dispensing training
and authorization to order, stock, manage and sell mifepristone; these obstacles are likely to …